Comparison of staging systems for extraocular retinoblastoma: Analysis of 533 patients

JAMA Ophthalmology

Volumn 131, Issue 9, 2013, Pages 1127-1134

  Chantada, Guillermo L ^a   Sampor, Claudia ^a   Bosaleh, Andrea ^a   Solernou, Verónica ^a   Fandiño, Adriana ^a   De Dávila, María T G ^a  

^a HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ANTERIOR EYE CHAMBER; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CENTRAL NERVOUS SYSTEM; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; ENUCLEATION; EXTRAOCULAR RETINOBLASTOMA; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; OPTIC NERVE; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; RETINOBLASTOMA; RETROSPECTIVE STUDY; RISK FACTOR; TUMOR INVASION;

BONE MARROW NEOPLASMS; BRAIN NEOPLASMS; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; EYE ENUCLEATION; FOLLOW-UP STUDIES; HUMANS; INFANT; NEOADJUVANT THERAPY; NEOPLASM INVASIVENESS; NEOPLASM STAGING; OPTIC DISK; OPTIC NERVE NEOPLASMS; RETINAL NEOPLASMS; RETINOBLASTOMA; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 84884552330     PISSN: 21686165     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaophthalmol.2013.260     Document Type: Article

References (29)

1. Chantada G, Doz F, Antoneli CB, et al. A proposal for an International Retinoblastoma Staging System. Pediatr Blood Cancer. 2006;47(6):801-805.
2. Rodríquez-Galindo C, Wilson MW, eds. Retinoblastoma. New York, NY: Springer; 2010.
3. Grabowski EF, Abramson DH. Intraocular and extraocular retinoblastoma. Hematol Oncol Clin North Am. 1987;1(4):721-735.
4. Pratt CB, Fontanesi J, Lu X, Parham DM, Elfervig J, Meyer D. Proposal for a new staging scheme for intraocular and extraocular retinoblastoma based on an analysis of 103 globes. Oncologist. 1997;2(1):1-5.
5. Broaddus E, Topham A, Singh AD. Survival with retinoblastoma in the USA: 1975-2004. Br J Ophthalmol. 2009;93(1):24-27.
6. Canturk S, Qaddoumi I, Khetan V, et al. Survival of retinoblastoma in less-developed countries: impact of socioeconomic and health-related indicators. Br J Ophthalmol. 2010;94(11):1432-1436.
7. Chantada GL, Doz F, Orjuela M, et al; International Retinoblastoma Staging Working Group. World disparities in risk definition and management of retinoblastoma: a report from the International Retinoblastoma Staging Working Group. Pediatr Blood Cancer. 2008;50(3):692-694.
8. Leal-Leal C, Flores-Rojo M, Medina-Sansón A, et al. A multicentre report from the Mexican Retinoblastoma Group. Br J Ophthalmol. 2004;88(8):1074-1077.
9. Luna-Fineman S, Barnoya M, Bonilla M, Fu L, Baez F, Rodríguez- Galindo C. Retinoblastoma in Central America: report from the Central American Association of Pediatric Hematology Oncology (AHOPCA). Pediatr Blood Cancer. 2012;58(4):545-550.
10. Linn Murphree A. Intraocular retinoblastoma: the case for a new group classification. Ophthalmol Clin North Am. 2005;18(1):41-53; viii.
11. Bakhshi S, Meel R, Kashyap S, Sharma S. Bone marrow aspirations and lumbar punctures in retinoblastoma at diagnosis: correlation with IRSS staging. J Pediatr Hematol Oncol. 2011;33(5):e182-e185.
12. Sastre X, Chantada GL, Doz F, et al; International Retinoblastoma Staging Working Group. Proceedings of the consensus meetings from the International Retinoblastoma Staging Working Group on the pathology guidelines for the examination of enucleated eyes and evaluation of prognostic risk factors in retinoblastoma. Arch Pathol Lab Med. 2009;133(8):1199-1202.
13. Zhao J, Dimaras H, Massey C, et al. Pre-enucleation chemotherapy for eyes severely affected by retinoblastoma masks risk of tumor extension and increases death from metastasis. J Clin Oncol. 2011;29(7):845-851.
14. Chantada GL, Casco F, Fandiño AC, et al. Outcome of patients with retinoblastoma and postlaminar optic nerve invasion. Ophthalmology. 2007;114(11):2083-2089.
15. Schvartzman E, Chantada G, Fandiño A, De Dávila MT, Raslawski E, Manzitti J. Results of a stage-based protocol for the treatment of retinoblastoma. J Clin Oncol. 1996;14(5):1532-1536.
16. Chantada G, Fandiño A, Dávila MT, et al. Results of a prospective study for the treatment of retinoblastoma. Cancer. 2004;100(4):834-842.
17. Chantada GL, Fandiño AC, Guitter MR, et al. Results of a prospective study for the treatment of unilateral retinoblastoma. Pediatr Blood Cancer. 2010;55(1):60-66.
18. Palma J, Sasso DF, Dufort G, et al. Successful treatment of metastatic retinoblastoma with high-dose chemotherapy and autologous stem cell rescue in South America. Bone Marrow Transplant. 2012;47(4):522-527.
19. Chantada GL, Rossi J, Casco F, et al. An aggressive bone marrow evaluation including immunocytology with GD2 for advanced retinoblastoma. J Pediatr Hematol Oncol. 2006;28(6):369-373.
20. Chintagumpala M, Chevez-Barrios P, Paysse EA, Plon SE, Hurwitz R. Retinoblastoma: review of current management. Oncologist. 2007;12(10):1237-1246.
21. Cuenca A, Giron F, Castro D, et al. Microscopic scleral invasion in retinoblastoma: clinicopathological features and outcome. Arch Ophthalmol. 2009;127(8):1006-1010.
22. Bosaleh A, Sampor C, Solernou V, et al. Outcome of children with retinoblastoma and isolated choroidal invasion. Arch Ophthalmol. 2012;130(6):724-729.
23. Magramm I, Abramson DH, Ellsworth RM. Optic nerve involvement in retinoblastoma. Ophthalmology. 1989;96(2):217-222.
24. Khelfaoui F, Validire P, Auperin A, et al. Histopathologic risk factors in retinoblastoma: a retrospective study of 172 patients treated in a single institution. Cancer. 1996;77(6):1206-1213.
25. Kaliki S, Shields CL, Shah SU, Eagle RC Jr, Shields JA, Leahey A. Postenucleation adjuvant chemotherapy with vincristine, etoposide, and carboplatin for the treatment of high-risk retinoblastoma. Arch Ophthalmol. 2011;129(11):1422-1427.
26. Dunkel IJ, Khakoo Y, Kernan NA, et al. Intensive multimodality therapy for patients with stage 4a metastatic retinoblastoma. Pediatr Blood Cancer. 2010;55(1):55-59.
27. Wilson MW, Rodriguez-Galindo C, Billups C, Haik BG, Laningham F, Patay Z. Lack of correlation between the histologic and magnetic resonance imaging results of optic nerve involvement in eyes primarily enucleated for retinoblastoma. Ophthalmology. 2009;116(8):1558-1563.
28. Radhakrishnan V, Kashyap S, Pushker N, et al. Outcome, pathologic findings, and compliance in orbital retinoblastoma (International Retinoblastoma Staging System stage III) treated with neoadjuvant chemotherapy: a prospective study. Ophthalmology. 2012;119(7):1470-1477.
29. Brisse HJ, Guesmi M, Aerts I, et al. Relevance of CT and MRI in retinoblastoma for the diagnosis of postlaminar invasion with normal-size optic nerve: a retrospective study of 150 patients with histological comparison. Pediatr Radiol. 2007;37(7):649-656.